People taking DMT tended to experience significant relief from their depression for up to three months, the researchers found ...

New CAPLYTA ® (lumateperone) Phase 3 analyses evaluating efficacy in achieving remission in adjunctive major depressive disorder (aMDD) to be presented SPRAVATO ® (esketamine) effects on anhedonia in ...

A new UT Austin clinical trial is testing a fast‑acting treatment for postpartum depression that doesn’t require drugs, anesthesia, or talk therapy. The therapy — known as SAINT neuromodulation — uses ...

Chronic stress can damage the gut’s protective lining, triggering inflammation that may worsen depression. New research shows that stress lowers levels of a protein called Reelin, which plays a key ...

The Flow FL-100 was recently okayed by the U.S. Food and Drug Administration as an at-home treatment for moderate to severe depression. The device is a wireless headset that delivers a low electrical ...

The new drug, called Esketamine and developed by Johnson & Johnson, is aimed at people with severe depression, particularly those with suicidal thinking. The new drug, called Esketamine and ...

Scientists have identified a pattern of gene activity present in some female survivors of childhood abuse that is associated with an elevated risk of depression. “We know childhood abuse increases the ...